12，Stiller RL， Davis PJ， McGowan FX， et al． In vitro metabo- 被引量：1
23，James MK．Remifentanil and anesthesia for the future．Experimental Opinion in Investigational Drugs，1994，3∶331． 被引量：1
34，Egan TD．Remifentanil pharmacokinetics and pharmacodynamics．A preliminary appraisal．Clinical Pharmacokinetics，1995，29∶80． 被引量：1
45，Hughes MA，Glass PSA，Jacobs JR．Context sensitive half-tine in multicompartment for intravenous anesthetic drugs．Anesthesiology，1992，76∶334． 被引量：1
56，Dershwitz M，Rosow CE，Michalowski P，et al．Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease compared with normal subjects．Anesthesiology，1994，81∶A377． 被引量：1
67，Hoke J， Muir K， Glass P， et al． Pharmacokinetics of remifentanil and its metabolite（GI90291）in subjects with renal diseases．Clin Ptharmacol Ther, 1995，57∶148． 被引量：1
78，Schuttler J，Albreght S，Breivik H，et al．A comparison of remifentanil and alfentanil in patients undergoing major abdominal surgery．Anaesthesia，1997，52∶307． 被引量：1
89，Hogue CW jr，Bowdle TA，O′Leary C，et al．A multicenter evaluation of total intravenous anesthesia with remifentanil and propofol for elective inpatient surgery．Anesth Analg，1996，83∶279． 被引量：1
910，Avramov M，Smith I，White PF．Use of midazolam and remifentanil during monitored anesthesian care （MAC）．Anesth Analg, 1995，80(Suppl)∶24． 被引量：1
